+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P09897(SNAPC1 Antibody) at dilution 1/40. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human tonsil tissue using P09897(SNAPC1 Antibody) at dilution 1/40. (Original magnification: ×200)    

  
  

**Background of SNAPC1 Antibody**

SNAPC1 (Small Nuclear RNA Activating Complex Polypeptide 1), also known as PTFγ or SNAP43. is a critical subunit of the SNAP complex (SNRNA Activating Protein complex), which plays a central role in the transcription of small nuclear RNA (snRNA) genes by RNA polymerase II and III. The SNAP complex binds to the proximal sequence element (PSE) in snRNA gene promoters, facilitating the assembly of the transcriptional machinery. SNAPC1 is the largest subunit of the complex and interacts with other components like SNAPC4 and Brf2 to stabilize promoter recognition and regulate transcription initiation.

Studies highlight SNAPC1's involvement in cellular processes such as RNA processing, cell cycle regulation, and ribosome biogenesis. Dysregulation of SNAPC1 has been linked to diseases, including cancer, where its overexpression or mutations may disrupt snRNA synthesis, impacting cell proliferation and survival. For instance, altered SNAPC1 expression has been observed in hepatocellular carcinoma and neuroblastoma.

Antibodies targeting SNAPC1 are essential tools for investigating its expression, localization, and function in vitro and in vivo. They are widely used in techniques like Western blotting, immunoprecipitation, and immunofluorescence to study SNAPC1’s role in gene regulation, its interaction partners, and its association with pathological conditions. These antibodies also aid in exploring therapeutic targets related to RNA polymerase III-dependent transcription and diseases linked to SNAP complex dysfunction.